Elizabeth Barrett

Insider Reports History

Entity
Individual
Location
C/O Urogen Pharma Ltd., 9 Ha'ta'asiya Street, Ra'anana, Israel
Signature
/s/Elizabeth Barrett
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Barrett:

Stock Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Chief Executive Officer Ordinary Shares 327K $5.88M $18.01 Jan 31, 2023 Direct
Allogene Therapeutics, Inc. Director Stock Option (Right to buy) 191K Jun 5, 2024 Direct
UroGen Pharma Ltd. Chief Executive Officer Employee Stock Option (right to buy) 125K Jan 31, 2023 Direct
UroGen Pharma Ltd. Chief Executive Officer Performance Stock Units 100K Jan 31, 2023 Direct
UroGen Pharma Ltd. Chief Executive Officer Restricted Stock Units 87.6K Jan 31, 2024 Direct

Insider Reports Filed by Elizabeth Barrett

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
URGN UroGen Pharma Ltd. Jan 31, 2024 1 $0 4 Feb 2, 2024 Chief Executive Officer
ALLO Allogene Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
URGN UroGen Pharma Ltd. Jan 31, 2023 7 $0 4 Feb 2, 2023 Chief Executive Officer
ALLO Allogene Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
URGN UroGen Pharma Ltd. Jan 31, 2022 7 -$62.1K 4 Feb 2, 2022 Chief Executive Officer
URGN UroGen Pharma Ltd. Jan 3, 2022 3 -$430K 4 Jan 7, 2022 Chief Executive Officer
ALLO Allogene Therapeutics, Inc. Jul 30, 2021 1 $0 4 Aug 3, 2021 Director
ALLO Allogene Therapeutics, Inc. Jul 30, 2021 0 $0 3 Aug 3, 2021 Director
URGN UroGen Pharma Ltd. Jan 3, 2021 6 -$60K 4 May 21, 2021 Chief Executive Officer
URGN UroGen Pharma Ltd. Jun 3, 2020 14 $0 4/A Jul 12, 2021 Chief Executive Officer
URGN UroGen Pharma Ltd. Feb 3, 2020 8 $0 4/A Jul 12, 2021 Chief Executive Officer